EpiVax Announces New CTO as Company Advances in Immunoinformatics Technology EpiVax, Inc. has announced Guilhem Richard as the new CTO, driving innovations and significant advancements in immunoinformatics technologies.

EpiVax Announces New CTO as Company Advances in Immunoinformatics Technology #USA #EpiVax #Guilhem_Richard #immunoinformatics #Providence,_R.I.

EpiVax Enhances Technological Leadership with Immunoinformatics Advances EpiVax proudly announces the appointment of Guilhem Richard as CTO, driving innovations in immunoinformatics technology for personalized cancer vaccines and therapeutic products.

EpiVax Enhances Technological Leadership with Immunoinformatics Advances #USA #EpiVax #Providence,_Rhode_Island #Guilhem_Richard #immunoinformatics

EpiVax Enhances Technology Leadership with the Appointment of Guilhem Richard EpiVax announces the appointment of Guilhem Richard as CTO, driving advancements in immunoinformatics and enhancing its technology leadership.

EpiVax Enhances Technology Leadership with the Appointment of Guilhem Richard #USA #Providence #EpiVax #Guilhem_Richard #immunoinformatics

EpiVax Appoints New CTO to Lead Immunoinformatics Innovations and Advancements EpiVax has appointed Guilhem Richard as its new Chief Technology Officer, enhancing its leadership in immunoinformatics and predictive tools for drug development.

EpiVax Appoints New CTO to Lead Immunoinformatics Innovations and Advancements #USA #EpiVax #Guilhem_Richard #immunoinformatics #Providence,_R.I.

EpiVax Appoints New CTO to Propel Innovations in Immunoinformatics EpiVax has announced the appointment of Guilhem Richard as Chief Technology Officer. His leadership aims to enhance immunoinformatics technologies significantly.

EpiVax Appoints New CTO to Propel Innovations in Immunoinformatics #USA #Providence #EpiVax #Guilhem_Richard #immunoinformatics